What is MiMedx Group Inc (MDXG)?
MiMedx Group Inc is a biopharmaceutical company that develops and markets regenerative biomaterial products derived from human placental tissue. These products are used primarily in wound care, surgical applications, and sports medicine to support tissue repair and healing. The company focuses on leveraging the natural properties of amniotic membrane and other placental tissues to promote regenerative healing processes. MiMedx Group serves healthcare providers and institutions with a portfolio that includes grafts and related biologic materials. The company operates within the regenerative medicine sector, emphasizing research and development in tissue preservation and therapeutic applications.
MiMedx Group Inc Stock Price Today: Live Overview
The price today is shaped by the intraday trading of MiMedx Group Inc, currently at $4.16. It has seen price movements between $4.07 and $4.16, reflecting a daily change of -2.1429%.
FAQ: MiMedx Group Inc (MDXG)
What is the current price of MDXG stock?
MiMedx Group Inc is trading at $4.16 at present.
Does MDXG pay dividends?
MiMedx Group Inc does not pay dividends.
Does MDXG have a formal corporate presence or regional headquarters in the UAE?
MiMedx Group Inc operates in the UAE through partnerships and does not have a direct office or subsidiary.
What is MDXG best known for?
MiMedx Group Inc is most famous for its regenerative biomaterial products.
What assets are typically shown together with MDXG?
Commonly shown alongside MDXG: iShares Silver Trust, Bubs Australia Limited, Toyota Motor Corporation
Latest shares articles



